New money making opportunities lie ahead. “This stock has a history of reporting, then selling off, and rallying again," Cramer said.» Read More
If you’re about say “Open sesame,” to shares of Alibaba, Jim Cramer doesn’t want you to get carried away. "I am blessing paying as high as..."
It’s one of the most controversial stocks in the market, but when bullish catalysts come together, Cramer can’t help himself.
If you’re looking to buy dips, Cramer wants you to know something.
There are plenty of reasons not to buy Alibaba. But do any of them tread water with Cramer?
Investors who weren’t sure how to position through year-end just received a message that couldn’t be more clear.
Cramer has been a fan of this stock for quite some time. However, he's just found another reason to buy and it's a big one.
Are you’re concerned that the global economy isn’t quite as perky as it had been?
Cramer spent Wednesday sifting through the Fed statement and the comments made by Fed chief Janet Yellen. They're quite telling.
Just because a stock is lower doesn’t necessarily make it bargain. Cramer turns to the technicals to better understand Apple.
Jim Cramer is always looking near and far for ideas. He just found something big.
Jim Cramer looks at what could drive the bull and what could send it scampering to the sidelines.
Cramer thinks pros are so eager to buy Alibaba they’re willing to throw away perfectly good stocks. That’s silly.
Cramer always says that investors need to watch the market like a hawk. This is why.
As the Alibaba IPO nears, Cramer expects a slew of stocks to selloff. He's naming names.
Underperformance in this stock may be nearing an end. Cramer thinks it belongs on your radar.
Sometimes different divisions of a company shouldn't be under the same roof. Cramer says this is one of those times.
Cramer thinks next week could be tough. “It’s not a bad idea to raise some cash,” he said.
Looking for new ideas as you put money to work in the stock market? Jim Cramer has plenty of them!
With some traditional drug companies starved for growth, Cramer thinks smaller biotechs may be in play.
For quite some time these two stocks seemed like they couldn’t lose. But then times changed.